Heart Beat: 02/09

The combination of an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker (CCB) proved more effective than an ACE inhibitor and a diuretic in reducing major cardiac events and mortality in a study of more than 11,000 men and women age 55 and older. The study, published in the Dec. 4 issue of the New England Journal of Medicine, was stopped early because the results of using the ACE inhibitor benazepril and the CCB amlodipine were so overwhelming. That combination of anti-hypertensive medications cut the risk of morbidity and mortality by 20 percent compared with the more conventional therapy of an ACE inhibitor and a diuretic, a common first-line approach against high blood pressure.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access